12 月13 日，CRO 行业翘楚药明康德正式在香港交易所IPO。这是该公司继登陆美国纽约证券交易所，上海交易所之后的第三次上市。今年4 月，港交所迎来新上市制度，允许未有收入的生物科技公司来香港上市，这对于需要大量资金进行产品开发的创新药企业而言可谓“雪中送炭”。

The North America molecular diagnostics market has been segmented based on products, test location, application, technology and geography. The product segment includes instruments, reagents and others. Application segment analyzed in this study include oncology, pharmacogenomics, infectious disease testing, genetic testing, neurological disease, cardiovascular disease, microbiology and others. Technology is segmented into PCR, In-situ hybridization, sequencing, chips and microarrays, INAAT, mass spectrometry, transcription mediated amplification and others. Test location segment includes point of care, OTC or selftests and central laboratories. In addition, country-wise market estimates and forecasts for all the previously mentioned segments have been included.

The Serbian pharmaceutical market is mid-sized in relation to the Central and Eastern European (CEE) region; larger than Slovenia yet smaller than Croatia and Kazakhstan. In terms of the country's pharmaceutical expenditure per capita, at just USD153, Serbia is grouped with countries such as Russia and Turkey, considerably below the regional average, highlighting the country's chronic under-spending on pharmaceuticals. Pharmaceutical sales in 2017 were worth RSD116bn (USD1.08bn), equating to 2.6% of GDP and 29.3% of total health expenditure. Serbia's pharmaceutical market is dominated by prescription drug sales (88% of total sales in 2017), of which generic medicines dominate (62% of total sales). Patented drugs accounted for 26% of total sales in 2017. OTC medicines, at 12% of total sales, are the smallest segment of the market. Serbia's Republic Health Insurance Fund (RFZO) provides full and partial reimbursement to insured citizens for pharmaceuticals placed on its positive Reimbursement List. Currently, the reimbursement list consists primarily of generic drugs and the market segmentation reflects this.

我国医保实行统筹支付，交医保金的人数对医保池的容量具有决定性作用。从 2020 年开始，我国 22-65 岁交医保金的人数开始下降，也将导致我国医保收入开始下降。

美国应对（AMR）治理问题设立特别小组协调多部门共同行动，对国家行动计划进行里程碑目标管理，并建立全美抗生素使用监测网络以指导行动实施。我国在实施AMR治理国家计划过程中，可设立专案小组作为枢纽机构推进计划，分解工作目标逐年追踪改善，建立医疗卫生数据的共享机制以完成监测网络。